Ignite Creation Date:
2025-12-24 @ 3:14 PM
Ignite Modification Date:
2026-02-02 @ 6:06 PM
Study NCT ID:
NCT03982992
Status:
WITHDRAWN
Last Update Posted:
2024-03-12
First Post:
2019-06-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Allogeneic Donor Lymphocyte Infusions Combined With Blinatumomab
Sponsor:
Ludwig-Maximilians - University of Munich
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2021-05-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-11-30
Completion Date Type:
ACTUAL
First Submit Date:
2019-06-03
First Submit QC Date:
None
Study First Post Date:
2019-06-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-07
Last Update Post Date:
2024-03-12
Last Update Post Date Type:
ACTUAL